Among them, anti-GPC3 mAb recognized GPC3, a tumorigenic fetal proteoglycan with high specific expression in HCC, to capture GPC3-positive HCC CTCs, while anti-VCAM1 mAb captured CTC-neutrophil clusters, and then DT dissociated the clusters. This evidence concerns the gene GPC3 and hepatocellular carcinoma.